David Rescott
Stock Analyst at Baird
(3.08)
# 1,162
Out of 4,944 analysts
67
Total ratings
43.64%
Success rate
2.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Maintains: Buy | $300 → $310 | $257.38 | +20.44% | 31 | Jul 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $78 → $79 | $77.68 | +1.70% | 5 | Jul 25, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $117 → $123 | $102.50 | +20.00% | 8 | Jul 24, 2025 | |
| HAE Haemonetics | Initiates: Outperform | $87 | $53.88 | +61.47% | 1 | Jun 26, 2025 | |
| MDT Medtronic | Maintains: Neutral | $94 → $92 | $92.91 | -0.98% | 6 | May 22, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $55 → $61 | $53.06 | +14.96% | 4 | May 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $86.15 | +27.68% | 3 | Apr 25, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $482.35 | +19.21% | 3 | Apr 23, 2025 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $15.70 | +65.61% | 6 | Dec 22, 2023 |
Penumbra
Jul 30, 2025
Maintains: Buy
Price Target: $300 → $310
Current: $257.38
Upside: +20.44%
Edwards Lifesciences
Jul 25, 2025
Maintains: Neutral
Price Target: $78 → $79
Current: $77.68
Upside: +1.70%
Boston Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $117 → $123
Current: $102.50
Upside: +20.00%
Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $53.88
Upside: +61.47%
Medtronic
May 22, 2025
Maintains: Neutral
Price Target: $94 → $92
Current: $92.91
Upside: -0.98%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55 → $61
Current: $53.06
Upside: +14.96%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $86.15
Upside: +27.68%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $482.35
Upside: +19.21%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $15.70
Upside: +65.61%